Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation
NCT01618383 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2016-12-01
Summary
The clinical and pathological similarities between LRRK2 related parkinsonism and idiopathic Parkinson's disease (PD) indicate that monogenetic LRRK2 parkinsonism may be a paradigm for the development of Lewy bodies disease, and a careful look at discrepancies between these two conditions may provide insight into the pathogenesis of PD. The early involvement of the enteric nervous system (ENS) during PD led to theories that an as yet unidentified external agent entering the ENS causes PD . If lesions of the ENS are found in patients who present with a genetic form of parkinsonism would go against this notion, and thus provide insight to the pathophysiology of the disease.
Conditions
Interventions
- OTHER
-
colonoscopy or rectosigmoidoscopy
Usual procedure
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Principal Investigators
-
Tiphaine ROUAUD, Doctor · Nantes University Hospital
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- France
Study Locations
More Related Trials
-
Study of Dysarthria, and the Appearance of Non-dopaminergic Signs in Idiopathic PARKinson's Disease
NCT03517059 ·Status: COMPLETED
-
Phosphorylation of ERK1/2 in Patients With Parkinson's Disease
NCT01142739 ·Status: COMPLETED
-
Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression
NCT01556100 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Deep Brain Stimulation on Gastrointestinal (GI) Motility
NCT01081457 ·Status: COMPLETED ·Phase: NA
-
Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease
NCT02289729 ·Status: COMPLETED
-
DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PD
NCT05579379 ·Status: UNKNOWN
-
Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study
NCT01044992 ·Status: COMPLETED ·Phase: NA
-
LIPAD - LRRK2 International Parkinson's Disease Study
NCT04214509 ·Status: UNKNOWN
-
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
NCT01484990 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Resistant Starch on Bowel Habits, Fecal Short Chain Fatty Acids and Gut Microbiota in Parkinson Disease
NCT02784145 ·Status: COMPLETED ·Phase: NA
-
Deep Brain Stimulation Therapy and Intestinal Microbiota
NCT04855344 ·Status: UNKNOWN
-
Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease
NCT06236230 ·Status: RECRUITING ·Phase: PHASE4
-
Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy
NCT02381444 ·Status: COMPLETED
-
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
NCT00335153 ·Status: COMPLETED ·Phase: PHASE3
-
Parkinson's KinetiGraph as Tool for DBS Eligibility Assessment
NCT02509325 ·Status: COMPLETED
-
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
NCT07151378 ·Status: RECRUITING ·Phase: PHASE3
-
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
NCT03872102 ·Status: RECRUITING
-
Deep Brain Stimulation and Digestive Symptomatology
NCT00639275 ·Status: COMPLETED
-
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
NCT02125825 ·Status: COMPLETED
-
Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease
NCT01014858 ·Status: TERMINATED ·Phase: PHASE3
-
[11C]Donepezil PET For Imaging The Autonomous Nervous System In Parkinsons Disease
NCT02012595 ·Status: COMPLETED
-
A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
NCT02857244 ·Status: WITHDRAWN ·Phase: PHASE2
-
Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Syndromes
NCT02445469 ·Status: TERMINATED ·Phase: NA
-
Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation
NCT02585154 ·Status: COMPLETED ·Phase: NA
-
Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders
NCT00001178 ·Status: TERMINATED